Cadherin 17 is frequently expressed by ‘sclerosing variant’ pancreatic neuroendocrine tumour

E-ISSN： 1365-2559|66|2|225-233

ISSN： 0309-0167

Source： HISTOPATHOLOGY, Vol.66, Iss.2, 2015-01, pp. : 225-233

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expression of cadherin 17 in well‐differentiated neuroendocrine tumours

HISTOPATHOLOGY, Vol. 66, Iss. 7, 2015-06 ,pp. : 1010-1021

John Wiley & Sons Inc

Access to resources Recommend Favorite

Transplant considerations in a man with von Hippel–Lindau disease with bilateral renal cell carcinoma and a pancreatic neuroendocrine tumour

NEPHROLOGY, Vol. 20, Iss. 12, 2015-12 ,pp. : 956-957

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lipid‐lowering therapy of everolimus‐related severe hypertriglyceridaemia in a pancreatic neuroendocrine tumour (pNET)

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 43, Iss. 1, 2018-02 ,pp. : 114-116

John Wiley & Sons Inc

Access to resources Recommend Favorite

E‐cadherin Expression is Frequently Reduced in Infiltrative Basal Cell Carcinoma

THE JOURNAL OF DERMATOLOGY, Vol. 27, Iss. 12, 2000-12 ,pp. : 804-805

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cytotoxic chemotherapy for pancreatic neuroendocrine tumors

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 22, Iss. 8, 2015-08 ,pp. : 628-633

John Wiley & Sons Inc

Access to resources Recommend Favorite